Cargando…

Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

It is unknown whether zoledronic acid (ZA) at clinically relevant doses is active against tumours not located in bone. Mice transgenic for the activated ErbB-2 oncogene were treated with a cumulative number of doses equivalent to that recommended in human beings. A significant increase in tumour-fre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coscia, Marta, Quaglino, Elena, Iezzi, Manuela, Curcio, Claudia, Pantaleoni, Francesca, Riganti, Chiara, Holen, Ingunn, Mönkkönen, Hannu, Boccadoro, Mario, Forni, Guido, Musiani, Piero, Bosia, Amalia, Cavallo, Federica, Massaia, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822730/ https://www.ncbi.nlm.nih.gov/pubmed/19818098 http://dx.doi.org/10.1111/j.1582-4934.2009.00926.x

Ejemplares similares

Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
por: Riganti, Chiara, et al.
Publicado: (2013)

Inhibition of the mevalonate pathway to override chemoresistance and promote the immunogenic demise of cancer cells: Killing two birds with one stone
por: Riganti, Chiara, et al.
Publicado: (2013)

Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP
por: Roelofs, Anke J, et al.
Publicado: (2009)

Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice
por: Bandini, Silvio, et al.
Publicado: (2013)

The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway
por: Wilson, Caroline, et al.
Publicado: (2015)

Zoledronic Acid Targeting of the Mevalonate Pathway Causes Reduced Cell Recruitment and Attenuates Pulmonary Fibrosis
por: Tanner, Lloyd, et al.
Publicado: (2022)

Zoledronate Extends Health Span and Survival via the Mevalonate Pathway in a FOXO-dependent Manner
por: Chen, Zhengqi, et al.
Publicado: (2021)

Modifying the osteoblastic niche with zoledronic acid in vivo—Potential implications for breast cancer bone metastasis
por: Haider, Marie-Therese, et al.
Publicado: (2014)

The kinetochore protein Cenp-F is a potential novel target for zoledronic acid in breast cancer cells
por: Brown, Hannah K, et al.
Publicado: (2011)

Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis
por: Macagno, Marco, et al.
Publicado: (2022)

Geranylgeraniol (GGOH) as a Mevalonate Pathway Activator in the Rescue of Bone Cells Treated with Zoledronic Acid: An In Vitro Study
por: Fliefel, Riham M., et al.
Publicado: (2019)

DNA vaccination against oncoantigens: A promise
por: Iezzi, Manuela, et al.
Publicado: (2012)

Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma
por: Castella, Barbara, et al.
Publicado: (2015)

Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells
por: Ubellacker, Jessalyn M., et al.
Publicado: (2017)

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells
por: Rigoni, Micol, et al.
Publicado: (2015)

Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways
por: Bruzzese, F, et al.
Publicado: (2013)

Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates
por: Wang, Shengdong, et al.
Publicado: (2018)

Liposome encapsulated zoledronate favours M1-like behaviour in murine macrophages cultured with soluble factors from breast cancer cells
por: Sousa, Sofia, et al.
Publicado: (2015)

Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma
por: Salaroglio, Iris Chiara, et al.
Publicado: (2014)

Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome
por: Haas, Dorothea, et al.
Publicado: (2006)

Pretreatment of breast cancer cells with doxorubicin facilitates the subsequent uptake of zoledronic acid
por: Lefley, DV, et al.
Publicado: (2008)

Antitumor immunization of mothers delays tumor development in cancer-prone offspring
por: Barutello, Giuseppina, et al.
Publicado: (2015)

Diagnostic value of urinary mevalonic acid excretion in mevalonate kinase deficiency (MKD)
por: Jeyaratnam, Jerold, et al.
Publicado: (2014)

ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells
por: Riganti, Chiara, et al.
Publicado: (2018)

The mevalonate pathway in C. Elegans
por: Rauthan, Manish, et al.
Publicado: (2011)

Mevalonate Metabolism in Immuno-Oncology
por: Gruenbacher, Georg, et al.
Publicado: (2017)

Mevalonate kinase somatic mosaicism and bigenic genotypes may explain heterogeneity in mevalonate kinase deficiency
por: Shinar, Y, et al.
Publicado: (2015)

Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice
por: Nanni, Patrizia, et al.
Publicado: (2001)

Mechanisms of apoptosis and cell-cycle arrest in subcutaneous breast tumours treated sequentially with doxorubicin followed by zoledronic acid
por: Ottewell, PD, et al.
Publicado: (2008)

Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells
por: Kopecka, Joanna, et al.
Publicado: (2011)

Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice
por: Calogero, Raffaele Adolfo, et al.
Publicado: (2007)

Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression
por: Castella, Barbara, et al.
Publicado: (2018)

Synthesis of Heterologous Mevalonic Acid Pathway Enzymes in Clostridium ljungdahlii for the Conversion of Fructose and of Syngas to Mevalonate and Isoprene
por: Diner, Bruce A., et al.
Publicado: (2017)

Diclofenac Prolongs Repolarization in Ventricular Muscle with Impaired Repolarization Reserve
por: Kristóf, Attila, et al.
Publicado: (2012)

iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
por: De Boo, Sara, et al.
Publicado: (2009)

Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
por: Neville-Webbe, H L, et al.
Publicado: (2010)

The bone microenvironment - Multiple players involved in cancer progression
por: Holen, Ingunn
Publicado: (2016)

Genomic variations of the mevalonate pathway in porokeratosis
por: Zhang, Zhenghua, et al.
Publicado: (2015)

Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
por: Rafiq, Nadia K., et al.
Publicado: (2018)

The Mevalonate Pathway Is Indispensable for Adipocyte Survival
por: Yeh, Yu-Sheng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pj5cvvbeia7aqheue98mkhu6d8